170 related articles for article (PubMed ID: 3492342)
1. In vitro and in vivo activity of coumermycin and other antibacterial agents against methicillin-resistant strains of Staphylococcus aureus.
Unowsky J; Chandrasekar PH; DeLorenzo W; Levine DP
Chemotherapy; 1986; 32(6):499-505. PubMed ID: 3492342
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of coumermycin, ofloxacin and vancomycin against methicillin-resistant Staphylococcus aureus in vitro and in experimental infections of mice.
Hirschl AM; Georgopoulos A; Stanek G; Breyer S; Rotter ML
Zentralbl Bakteriol Mikrobiol Hyg A; 1988 Mar; 267(4):541-8. PubMed ID: 3164157
[TBL] [Abstract][Full Text] [Related]
3. Activity of eleven antimicrobial agents against methicillin-, methicillin- and rifampin-resistant Staphylococcus aureus.
Chokkavelu V; Chandrasekar P; Rolston K; LeFrock JL; Schell RF
Chemotherapy; 1984; 30(2):97-101. PubMed ID: 6559665
[TBL] [Abstract][Full Text] [Related]
4. Comparative in vitro activity of coumermycin against methicillin-resistant Staphylococcus aureus.
Meyers BR; Srulevitch ES; Hirschman SZ
Antimicrob Agents Chemother; 1985 Nov; 28(5):706-7. PubMed ID: 3853964
[TBL] [Abstract][Full Text] [Related]
5. In-vitro activity of coumermycin against methicillin-resistant staphylococci: a comparison with six other agents.
Thomas MG; Lang SD
J Antimicrob Chemother; 1986 Aug; 18(2):171-5. PubMed ID: 3639086
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo efficacy of the combination trimethoprim-sulfamethoxazole against clinical isolates of methicillin-resistant Staphylococcus aureus.
Elwell LP; Wilson HR; Knick VB; Keith BR
Antimicrob Agents Chemother; 1986 Jun; 29(6):1092-4. PubMed ID: 3488022
[TBL] [Abstract][Full Text] [Related]
7. Activity of coumermycin against clinical isolates of staphylococci.
Guillemin MN; Miles HM; McDonald MI
Antimicrob Agents Chemother; 1986 Apr; 29(4):608-10. PubMed ID: 3707109
[TBL] [Abstract][Full Text] [Related]
8. Gentamicin- and methicillin-resistant Staphylococcus aureus: in vitro susceptibility to antimicrobial drugs.
Traub WH; Spohr M; Bauer D
Chemotherapy; 1987; 33(5):361-75. PubMed ID: 3665635
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial activity of coumermycin and recommendations for disk diffusion tests with 5- and 15-micrograms disks.
Jones RN; Barry AL
Diagn Microbiol Infect Dis; 1987 May; 7(1):77-82. PubMed ID: 3691036
[TBL] [Abstract][Full Text] [Related]
10. In vitro activity of coumermycin alone or in combination against Staphylococcus aureus and Staphylococcus epidermidis.
Van der Auwera P; Klastersky J
Drugs Exp Clin Res; 1986; 12(4):307-11. PubMed ID: 3013562
[TBL] [Abstract][Full Text] [Related]
11. Gentamicin- and methicillin-resistant, clinical isolates of Staphylococcus aureus: comparative in vitro and in vivo efficacy of alternative antimicrobial drugs.
Traub WH; Spohr M; Bauer D
Chemotherapy; 1984; 30(2):102-12. PubMed ID: 6559664
[TBL] [Abstract][Full Text] [Related]
12. In-vitro effects of vancomycin, rifampicin, and fusidic acid, alone and in combination, against methicillin-resistant Staphylococcus aureus.
Foldes M; Munro R; Sorrell TC; Shanker S; Toohey M
J Antimicrob Chemother; 1983 Jan; 11(1):21-6. PubMed ID: 6826485
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo activities of echinomycin against clinical isolates of Staphylococcus aureus.
Park YS; Shin WS; Kim SK
J Antimicrob Chemother; 2008 Jan; 61(1):163-8. PubMed ID: 17967852
[TBL] [Abstract][Full Text] [Related]
14. In vitro activities of teichomycin, fusidic acid, flucloxacillin, fosfomycin, and vancomycin against methicillin-resistant Staphylococcus aureus.
Guenthner SH; Wenzel RP
Antimicrob Agents Chemother; 1984 Aug; 26(2):268-9. PubMed ID: 6237606
[TBL] [Abstract][Full Text] [Related]
15. In-vitro and in-vivo studies of trimethoprim-sulphamethoxazole against multiple resistant Staphylococcus aureus.
Yeldandi V; Strodtman R; Lentino JR
J Antimicrob Chemother; 1988 Dec; 22(6):873-80. PubMed ID: 3266621
[TBL] [Abstract][Full Text] [Related]
16. Oral fusidic acid fails to eradicate methicillin-resistant Staphylococcus aureus colonization and results in emergence of fusidic acid-resistant strains.
Chang SC; Hsieh SM; Chen ML; Sheng WH; Chen YC
Diagn Microbiol Infect Dis; 2000 Feb; 36(2):131-6. PubMed ID: 10705056
[TBL] [Abstract][Full Text] [Related]
17. Growing Resistance to Vancomycin among Methicillin Resistant Staphylococcus Aureus Isolates from Different Clinical Samples.
Pahadi PC; Shrestha UT; Adhikari N; Shah PK; Amatya R
JNMA J Nepal Med Assoc; 2014; 52(196):977-81. PubMed ID: 26982895
[TBL] [Abstract][Full Text] [Related]
18. The in-vitro activity of some antimicrobial agents against methicillin-resistant Staphylococcus aureus.
Moorhouse EC; Mulvihill TE; Jones L; Mooney D; Falkiner FR; Keane CT
J Antimicrob Chemother; 1985 Mar; 15(3):291-5. PubMed ID: 3158632
[TBL] [Abstract][Full Text] [Related]
19. Treatment of Staphylococcus aureus endocarditis in rats with coumermycin A1 and ciprofloxacin, alone or in combination.
Perronne CM; Malinverni R; Glauser MP
Antimicrob Agents Chemother; 1987 Apr; 31(4):539-43. PubMed ID: 3606060
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the activities of coumermycin, ciprofloxacin, teicoplanin, and other non-beta-lactam antibiotics against clinical isolates of methicillin-resistant Staphylococcus aureus from various geographical locations.
Aldridge KE; Janney A; Sanders CV
Antimicrob Agents Chemother; 1985 Nov; 28(5):634-8. PubMed ID: 2936300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
